Skip to main content

NANOPARTICULAS MULTIFUNCIONALES PARA LA OBTENCION DE BIOIMAGENES MEDIANTE LUMINISCENCIA, RESONANCIA MAGNETICA Y TOMOGRAFIA COMPUTARIZADA DE RAYOS X

PRE2019-090170

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de Promoción del Talento y su Empleabilidad en I+D+i
Subprogram Subprograma Estatal de Formación
Call Contratos Predoctorales
Call year 2019
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Europium doped-double sodium bismuth molybdate nanoparticles as contrast agents for luminescence bioimaging and X-ray computed tomography

  • Calderón-Olvera, Roxana M.
  • Núñez, Nuria O.
  • González-Mancebo, Daniel
  • Monje-Moreno, José Manuel
  • Muñoz-Ruiz, Manuel
  • Gómez-González, Elisabet
  • Arroyo, Encarnación
  • Torres Herrero, Beatriz
  • Fuente, Jesús M. de la
  • Ocaña, Manuel
A one-pot method for the synthesis of uniform Eu3+-doped NaBi(MoO4)2 nanoparticles with an ellipsoidal shape and tetragonal crystal structure functionalized with polyacrylic acid is reported for the first time in the literature. The method is based on a homogeneous precipitation reaction from solutions in an ethylene glycol/water medium containing appropriate bismuth, sodium, and molybdate precursors and polyacrylic acid. The luminescence properties (excitation and emission spectra and luminescence lifetime) of such nanoparticles are evaluated for different Eu3+ doping levels, finding an intense red emission for all synthesized samples. The X-ray attenuation properties of the nanoparticles have been also analyzed, which were found to be better than those of a commercially computed tomography contrast agent (iohexol). The dispersibility of the nanoparticles in a physiological medium was also analyzed, finding that they could be well dispersed in a 2-N-morpholinoethanesulfonic acid monohydrate medium (pH = 6.5). Finally, the cell viability of such a phosphor has been analyzed using MIA-PaCa-2 cells and its in vivo toxicity has been evaluated using the nematode Caenorhabditis elegans model finding no significant toxicity in both cases up to a nanoparticle concentration of 100 μg mL−1, which is within the range required for most in vivo applications. The developed Eu3+-doped NaBi(MoO4)2 nanoparticles are, therefore, excellent candidates for their use as bimodal probes for luminescence imaging and X-ray computed tomography., This publication is part of the I + D + I Grant RTI2018-094426-B-I00 and funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”. R. M. Calderón-Olvera acknowledges the financial support from the CONACYT-801024 postdoctoral grant. E. Gómez-González acknowledges the financial support from the FPI program (PRE2019-090170). E. Arroyo acknowledges the grant FPU19/00527 funded by MCIN/AEI/10.13039/501100011033 and by “ESF Investing in your future”. B. T. is grateful for the FPU predoctoral contract (FPU19/01311) from Ministerio de Educación Cultura y Deporte (Spain). J. M. de la Fuente thanks DGA and Fondos Feder (Bionanosurf E15_17R) and CIBER-Consorcio Centro de Investigación Biomédica en Red (CB16/01/00263), Instituto de Salud Carlos III (Spanish Ministry of Science and Innovation and European Commission, European Regional Development Fund). This research was also funded by the European Commission NextGenerationEU (Regulation EU 2020/2094).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Carboxylate functionalized NaDy(MoO4)2 nanoparticles with tunable size and shape as high magnetic field MRI contrast agents

  • Gómez-González, Elisabet
  • Núñez, Nuria O.
  • Caro, Carlos
  • García-Martín, María L.
  • Ocaña, Manuel
Uniform sodium-dysprosium double molybdate (NaDy(MoO4)2) nanoparticles having different morphologies (spheres and ellipsoids) and tunable size have been synthesized for the first time in literature. The procedure is based on a homogeneous precipitation process at moderated temperatures (≤220 °C) from solutions containing appropriated precursors dissolved in ethylene glycol-water mixtures, in the absence (spheres) or the presence (ellipsoids) of tartrate anions. The effects of the morphological characteristics (size and shape) of the nanoparticles on the magnetic relaxivity at high field (9.4 T) have been evaluated finding that the latter magnitude was higher for the spheres than for the ellipsoids, indicating their better suitability as contrast agents for high-field magnetic resonance imaging. Such nanoparticles have been successfully coated with polymers bearing carboxylate functional groups through a layer-by-layer process, which improves the colloidal stability of the nanoparticles in physiological media. It has been also found that the coating layer had no significant effects on the nanoparticles relaxivity and that such coated nanoparticles exhibited a high biocompatibility and a high chemical stability. In summary, we have developed NaDy(MoO4)2 based bioprobes which meet the required criteria for their use as contrast agents for high-field magnetic resonance imaging., This publication is part of the I + D + I Grants RTI2018-094426-B-I00 and CTQ2017-86655-R funded by MCIN/AEI/ 10.13039/501100011033 and by “ERDF A way of making Europe”. Financial support was also provided by Junta de Andalucía (P20_00182). E. Gómez-González acknowledges the financial support from the FPI program (PRE2019-090170)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Lanthanide vanadate-based trimodal probes for near-infrared luminescent bioimaging, high-field magnetic resonance imaging, and X-ray computed tomography

  • Gómez-González, Elisabet
  • González-Mancebo, Daniel
  • Núñez, Nuria O.
  • Caro, Carlos
  • García-Martín, María L.
  • Becerro, Ana Isabel
  • Ocaña, Manuel
We have developed a trimodal bioimaging probe for near-infrared luminescent imaging, high-field magnetic resonance imaging, and X-ray computed tomography using Dy3+ as the paramagnetic component and Nd3+ as the luminescent cation, both of them incorporated in a vanadate matrix. Among different essayed architectures (single phase and core–shell nanoparticles) the one showing the best luminescent properties is that consisting of uniform DyVO4 nanoparticles coated with a first uniform layer of LaVO4 and a second layer of Nd3+-doped LaVO4. The magnetic relaxivity (r2) at high field (9.4 T) of these nanoparticles was among the highest values ever reported for this kind of probes and their X-ray attenuation properties, due to the presence of lanthanide cations, were also better than those of a commercial contrast agent (iohexol) commonly used for X-ray computed tomography. In addition, they were chemically stable in a physiological medium in which they could be easily dispersed owing to their one-pot functionalization with polyacrylic acid, and, finally, they were non-toxic for human fibroblast cells. Such a probe is, therefore, an excellent multimodal contrast agent for near-infrared luminescent imaging, high-field magnetic resonance imaging, and X-ray computed tomography., Financial support by Junta de Andalucía (P20_00182) is acknowledged. This publication is part of the I + D + I Grants RTI2018-094426-B-I00, PID2021-122328OB-I00, and PID2020-118448RB-C21, funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”. Grant PRE2019-090170 funded by MCIN/AEI/10.13039/501100011033 and by “ESF Investing in your future” is also acknowledged. High-field relaxivity measurements were performed at the ICTS “NANBIOSIS”, specifically in Unit 28 at the “Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina (IBIMA Plataforma BIONAND)”., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Lanthanide vanadate-based nanoparticles as multimodal T1 -T2 MRI contrast agent and NIR luminescent imaging probe

  • Gómez-González, Elisabet
  • Núñez, Nuria O.
  • Caro, Carlos
  • García-Martín, María L.
  • Becerro, Ana Isabel
  • Ocaña, Manuel
We report the development of a multimodal lanthanide vanadate system suitable as dual T1-T2 MRI contrast agent as well as a luminescent imaging probe in the near-infrared region, using Dy3+ and Gd3+ as T2 and T1 components, respectively, and Nd3+ as the luminescent center. The vanadate matrix was chosen to avoid the undesired solubility associated to previously reported fluoride-based contrast agents. With such aim, we first optimized the design of the MRI system by comparatively evaluating the magnetic relaxivities of two different architectures consisting of i) uniform NPs incorporating both paramagnetic cations in solid solution (single-phase NPs), and ii) core-shell NPs consisting of a DyVO4 core coated with a homogeneous GdVO4 shell (DyVO4@GdVO4). We found that, although both samples presented magnetic relaxivity properties that make them adequate for their use as dual T1-T2 contrast agents for magnetic resonance imaging, the core-shell architecture would be more suitable because of their higher magnetic relaxivity values. Secondly, to prepare the multimodal system, the GdVO4 layer of such optimal dual T1-T2 MRI probe was doped with Nd3+ cations. An inert YVO4 intermediate shell was also introduced between the cores and the outer layer aiming to avoid energy transfer from Nd3+ to Dy3+, which would cause luminescence quenching. These core-shell-shell nanoparticles showed magnetic relaxivity values similar to those of the core-shell system and an intense luminescence in the near-infrared region. Moreover, they were dispersible and chemically stable under conditions that mimic the physiological media, and they were nontoxic for cells. Therefore, such multimodal nanoparticles meet the main requirements for their use as a dual T1-T2 contrast agent for magnetic resonance imaging and as a probe for luminescent imaging in the near-infrared region., This publication is part of the I + D + I Grants PID2021-122328OB-I00 and PID2020-118448RB-C21, funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”. This work was supported as well by Junta de Andalucía under grant no. P20_00182, co-financed by EU FEDER funds. Grant PRE2019-090170 funded by MCIN/AEI/10.13039/501100011033 and by “ESF Investing in your Future” is also acknowledged. Relaxivity measurements were performed at the ICTS “NANBIOSIS”, specifically in Unit 28 at the “Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina (IBIMA Plataforma BIONAND)”., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Sodium lanthanide tungstate-based nanoparticles as bimodal contrast agents for in vivo high-field MRI and CT imaging

  • Gómez-González, Elisabet
  • Caro, Carlos
  • Núñez, Nuria O.
  • González-Mancebo, Daniel
  • Urbano-Gámez, Jesús D.
  • García-Martín, María L.
  • Ocaña, Manuel
Research on High-Field Magnetic Resonance Imaging (HF-MRI) has increased in recent years, aiming to improve diagnosis accuracy by increasing the signal-to-noise ratio and hence image quality. Conventional contrast agents (CAs) have important limitations for HF-MRI, with the consequent need for the development of new CAs. Among the most promising alternatives are those based on Dy3+ or Ho3+ compounds. Notably, the high atomic number of lanthanide cations would bestow a high capability for X-ray attenuation to such Dy or Ho-based compounds, which would allow them to be also employed as CAs for X-ray computed tomography (CT). In this work, we have prepared uniform NaDy(WO4)2 and NaHo(WO4)2 nanoparticles NPs, which were dispersible under conditions that mimic the physiological media and were nontoxic for cells, meeting the main requirements for their use in vivo. Both NPs exhibited satisfactory magnetic relaxivities at 9.4T, thus making them a promising alternative to clinical CAs for HF-MRI. Furthermore, after their intravenous administration in tumor-bearing mice, both NPs exhibited significant accumulation inside the tumor at 24 h, attributable to passive targeting by the Enhanced Permeability and Retention (EPR) effect. Therefore, our NPs are suitable for detection of tumors through HF-MRI. Finally, NaDy(WO4)2 NPs showed a superior X-ray attenuation capability than iohexol (commercial CT CA), which, along with their high r2 value, makes them suitable as dual-probe for dual HF-MRI and CT imaging, as demonstrated by in vivo experiments conducted using healthy mice., This publication is part of the I + D + I Grants PID2021-122328OB-I00 and PID2020-118448RB-C21, funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”. This work was supported as well by Junta de Andalucía under grant no. P20_00182, co-financed by EU FEDER funds. Grant PRE2019-090170 funded by MCIN/AEI/10.13039/501100011033 and by “ESF Investing in your future” is also acknowledged. Relaxivity measurements were performed at the ICTS “NANBIOSIS”, specifically in Unit 28 at the “Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina (IBIMA Plataforma BIONAND)”., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Sodium lanthanide tungstate-based nanoparticles as bimodal probes for T1-T2 magnetic resonance imaging and X-ray computed tomography

  • Gómez-González, Elisabet
  • Núñez, Nuria O.
  • Caro, Carlos
  • García-Martín, María L
  • Monje-Moreno, José Manuel
  • Hamdi, Amel
  • López-Larrubia, Pilar
  • Becerro, Ana Isabel
  • Ocaña, Manuel
Magnetic resonance imaging (MRI) is one of the most used imaging techniques for diagnosis in clinics. Often, magnetically-active substances, called contrast agents (CAs), have to be used, Creative Commons Attribution-NonCommercial 3.0 Unported Licence. Open Access Article. Published on 10 October 2025. Downloaded on 10/10/2025 10:25:41 AM. This article is licensed under a which increase contrast by shortening the longitudinal (T1) (resulting in signal enhancement in T1-weigthed images) and/or transverse (T2) (resulting in signal decay in T2-weighted images) relaxation times of the water protons present in biological tissues. A further strategy to improve diagnostic accuracy is recording both kinds of images (T1-weighted and T2-weighted) using dual T1-T2 CAs, which facilitates the exclusion of false positives. The traditional T1 or T2 contrast agents are not suitable for such a purpose. This paper deals with the development of double sodium lanthanide tungstate-based nanoparticles containing Gd3+ and Dy3+ cations, which are dispersible in physiological media, do not show appreciable in vitro (for human fibroblast cells) and in vivo (for C-elegans) toxicity and present appropriate relaxivity values for their use as a dual T1-T2 contrast agent for magnetic resonance imaging. In addition, they show an excellent X-ray attenuation capacity, thanks, mainly, to their tungsten content, which makes them also useful for X-ray computed tomography. Hence, the developed nanoparticles are ideal multimodal probes to be used as a dual T1-T2 contrast agent for magnetic resonance imaging and as a contrast agent for X-ray computed tomography., This publication is part of the I + D + I Grants PID2021-122328OB-I00, PID2020118448RB-C21 and PID2021-122528OB-I00, funded by MICIU/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”. Financial support was also provided by Junta de Andalucía (P20_00182). DIAMOND network RED2022-134299-T funded by MICIN and grant PRE2019-090170 funded by MCIN/AEI/10.13039/501100011033 and by “ESF Investing in your future” are also acknowledged. Relaxivity measurements were performed at the ICTS “NANBIOSIS”, specifically in Unit 28 at the “Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina (IBIMA Plataforma BIONAND)”., Peer reviewed